Trial intelligence / Profile preview

Testosterone and Metformin for Obesity-induced Male Hypogonadism

NCT02514629Phase 3Completed

Start
Jul 2013
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of metformin, testosterone undecanoate in Hypogonadism. Started Jul 2013; status: completed.

02

Drugs

metformintestosterone undecanoate
03

Conditions

Hypogonadism

Beyond the preview

Go deeper on NCT02514629.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02514629.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call